Tech Support

Nervous yet ready...

The Growing Preference for Minimally Invasive Treatments and Injectable Collagenease Driving the Global Dupuytren’s Contracture Market

The global Dupuytren’s Contracture Market is witnessing significant growth, primarily fueled by the increasing prevalence of this progressive, debilitating fibrotic disorder of the hand, coupled with rising patient and physician awareness regarding effective treatment options. Dupuytren’s Contracture, often referred to as "Viking disease," involves the thickening and shortening of the fascia beneath the skin of the palm, eventually causing one or more fingers to curl into the palm, resulting in functional impairment. The primary market driver is the shift from highly invasive open surgical procedures, such as fasciectomy, toward minimally invasive techniques that offer shorter recovery times, reduced hospital stays, and better cosmetic outcomes. Among these, Collagenase Clostridium Histolyticum (CCH), an injectable enzyme that chemically breaks down the fibrotic cords, has revolutionized the treatment landscape. Its non-surgical nature and proven efficacy for early and…

Nervous yet ready...